3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Conditions
Neoplasms
3
Cancer Pain
2
Osteoarthritis
1
Lymphoma, Follicular
1
Back Pain
1
Interventions
Oxycodone
9
Fentanyl
5
Morphine
3
Ethanol
3
Naloxone
2
Buprenorphine
2
Acetaminophen
2
rofecoxib
1
Ultracet
1
Radiofrequency Ablation
1
Polyethylene Glycols
1
Methadone
1
Magnesium Hydroxide
1
Hydromorphone
1
Electrolytes
1
Duration of Therapy
1
Dosage Forms
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Cancer Pain
×
Naloxone
×
Clear all
NCT01313780
2017-12-22
TOP
Mundipharma Korea Ltd
Phase 4
Completed
128 enrolled
8 charts
NCT01719757
2016-08-19
PROBE
Mundipharma Korea Ltd
Phase 4
Completed
359 enrolled
10 charts